INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 53 filers reported holding INTEC PHARMA LTD JERUSALEM in Q2 2019. The put-call ratio across all filers is 26.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $308,000 | -31.4% | 71,000 | -10.8% | 0.00% | – |
| Q3 2018 | $449,000 | -42.3% | 79,632 | -55.0% | 0.00% | – |
| Q2 2018 | $778,000 | +718.9% | 176,842 | +1070.2% | 0.00% | – |
| Q1 2018 | $95,000 | -84.0% | 15,112 | -86.9% | 0.00% | – |
| Q4 2017 | $593,000 | -8.3% | 115,217 | +59.2% | 0.00% | – |
| Q3 2017 | $647,000 | +346.2% | 72,350 | +184.3% | 0.00% | – |
| Q2 2017 | $145,000 | +123.1% | 25,450 | +100.0% | 0.00% | – |
| Q1 2017 | $65,000 | +3.2% | 12,724 | +13.6% | 0.00% | – |
| Q4 2016 | $63,000 | -50.0% | 11,200 | -47.9% | 0.00% | – |
| Q3 2016 | $126,000 | – | 21,477 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|